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Abstract. 
 
The purpose of this study was to evaluate the 
effect of neurotrophin 3 (NT-3) enhanced nerve regen-
eration on the reinnervation of a target muscle. Muscle 
fibers can be classified according to their mechanical 
properties and myosin heavy chain (MHC) isoform 
composition. MHC1 containing slow-type and MHC2a 
or 2b fast-type fibers are normally distributed in a mo-
saic pattern, their phenotype dictated by motor inner-
vation. After denervation, all fibers switch to fast-type 
MHC2b expression and also undergo atrophy resulting 
in loss of muscle mass. After regeneration, discrimina-
tion between fast and slow fibers returns, but the distri-
bution and fiber size change according to the level of 
reinnervation. 
In this study, rat gastrocnemius muscles (ipsilateral 
and contralateral to the side of nerve injury) were col-
lected up to 8 mo after nerve repair, with or without lo-
cal delivery of NT-3. The phenotype changes of MHC1, 
2a, and 2b were analyzed by immunohistochemistry, 
and fiber type proportion, diameter, and grouping were 
assessed by computerized image analysis. At 8 mo, the 
local delivery of NT-3 resulted in significant improve-
ment in gastrocnemius muscle weight compared with 
controls (NT-3 group 47%, controls 39% weight of con-
 
tralateral normal muscle;
 
 P 
 
, 
 
0.05). NT-3 delivery re-
sulted in a significant increase in the proportion (NT-3 
43.3%, controls 35.7%;
 
 P 
 
, 
 
0.05) and diameter (NT-3 
87.8 
 
m
 
m, controls 70.8 
 
m
 
m;
 
 P 
 
, 
 
0.05) of fast type 2b fi-
bers after reinnervation. This effect was specific to type 
2b fibers; no normalization was seen in other fiber 
types.
This study indicates that NT-3–enhanced axonal re-
generation has a beneficial effect on the motor target 
organ. Also, NT-3 may be specifically affecting a subset 
of motoneurons that determine type 2b muscle fiber 
phenotype. As NT-3 was topically applied to cut 
nerves, our data suggest a discriminating effect of the 
neurotrophin on neuro–muscular interaction. These re-
sults would imply that muscle fibers may be differen-
tially responsive to other neurotrophic factors and indi-
cate the potential clinical role of NT-3 in the prevention 
of muscle atrophy after nerve injury.
 
T
 
here
 
 has been much recent interest in the use of
growth factors to augment peripheral nerve regen-
eration. A family of growth factors collectively
 
known as the neurotrophins are now considered critical
for the development, maintenance, and regeneration of
the nervous system. The neurotrophin family includes NGF,
brain derived neurotrophic factor (BDNF), neurotrophin-3
(NT-3),
 
1
 
 and neurotrophin-4/5 (NT-4/5) (Lewin and Barde,
1996; Lindsay, 1996). Little is known of their effect on re-
generation of the peripheral nervous system.
NT-3 has been shown to act on a subpopulation of mus-
cle sensory neurons innervating muscle spindles and Golgi
tendon organs, and there is also evidence of its effect on a
subpopulation of cutaneous afferents (Ernfors et al., 1994;
Tessarolo et al., 1994; Airaksinen et al., 1996). NT-3 has
shown various effects on motor nerve regeneration, in-
cluding differentiation of motoneurons from avian neural
tube progenitor cells (Averbuch-Heller et al., 1994) and
survival of neonatal and adult motoneurons in vitro
(Hughes et al., 1993) and of neonatal motoneurons in vivo
(Li et al., 1994; Vejsada et al., 1995), although the evidence
is sometimes contradictory
 
 
 
(Eriksson et al., 1994). In cocul-
tures of adult muscle and embryonic motoneurons, NT-3
enhances the number and length of neurite outgrowths,
the density of endplates per muscle fiber, and the amount
 
Address all correspondence to Dr. G.Terenghi, Blond McIndoe Centre,
Queen Victoria Hospital, Holtye Road, East Grinstead, West Sussex
RH19 3DZ, United Kingdom. Tel.: 01342 313088. Fax: 01342 301701. E-mail:
terenghi@dial.pipex.com
 
1. 
 
Abbreviations used in this paper
 
: ANOVA, analysis of variance; FN, fi-
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The Journal of Cell Biology, Volume 139, 1997 710
 
of muscle innervation (Braun et al., 1996). NT-3 also plays
a role in functional maturation of neuromuscular synapses
(Lohoff et al., 1993; Wang et al., 1995) and regulates the
cholinergic phenotype of developing motoneurons (Wong
et al., 1993; Kato and Lindsay, 1994). NT-3 knockout mice
show a loss of all muscle spindle afferent innervation and
fusimotor neurons to the muscle but lose only few skeleto-
motor nerve fibers (Kucera et al., 1995
 
a
 
). About 80% of
adult motoneurons express the NT-3–specific trkC recep-
tor (Henderson et al., 1993; Griesbeck et al., 1995), and
NT-3 is the predominant neurotrophin expressed in skele-
tal muscle (Griesbeck et al., 1995). Furthermore, NT-3 is
internalized and retrogradely transported from the periph-
ery to motoneuron cell bodies (Di Stefano et al., 1992).
Thus, there is experimental and circumstantial evidence to
suggest that NT-3 may play a role in adult motoneurons,
although
 
 
 
in vivo data on the survival effect of NT-3 on
adult motoneurons is still lacking. Furthermore, there is
no evidence of an NT-3–dependent effect on neuro–mus-
cular interaction.
When a skeletal muscle is denervated and subsequently
reinnervated, a characteristic sequence of events ensues.
The muscle rapidly loses weight as the muscle fibers atro-
phy (Pellegrino and Franzini, 1963), but after reinnervation,
it gradually recovers mass to a variable extent, depending
upon the degree of reinnervation (Bertelli and Mira, 1995)
and correlating with the maximum force of contraction (Gil-
lespie et al., 1987). The fibers within an individual skeletal
muscle do not exist as a homogenous population but can
be classified according to their different metabolic and con-
tractile properties (Burke et al., 1971; Peter et al., 1972).
Also, they can be identified morphologically according to
differential expression of specific myosin heavy chain iso-
forms. Slow, oxidative type 1 muscle fibers contain myosin
heavy chain 1 (MHC 1), fast oxidative glycolytic type 2a
fibers contain myosin heavy chain 2a (MHC 2a), while fast
glycolytic type 2b fibers contain myosin heavy chain 2b
(MHC 2b) (Bar and Pette, 1988). Muscle fiber phenotype is
conferred by its innervation, and changes of neuro–muscu-
lar interaction lead to alteration of muscle fiber phenotype
(Romanul and Van der Meulen, 1966; Fex and Sonneson,
1970; Salmons and Sreter, 1975). The relative proportions
of fiber types vary with age, sex, strain, species, and muscle
type (Maltin et al., 1989). Generally, there is a high propor-
tion of type 1 fibers in postural muscles (e.g., soleus) and
of type 2 fibers in fast muscles (e.g., extensor digitorum
longus), while in mixed muscles (e.g., gastrocnemius) there
are varying proportions of each type. Muscle fiber type
proportion also varies dynamically with physiological and
pathological parameters (Jansson et al., 1978; Green et al.,
1983; Izumo et al., 1986; Goldspink et al., 1992; Pette and
Vrbova, 1992). For example, the distribution of fiber types
in normal muscle is dispersed in a “mosaic pattern,” but
after denervation and reinnervation of the muscle there is
a shift to grouping (Karpati and Engel, 1968). Also, there
is a change in the proportions of fiber types, and in the rat
the majority of fibers become initially fast with denerva-
tion, with subsequent fiber specialization being dictated by
patterns of reinnervation (Fields and Ellisman, 1986). This
plastic nature of muscle makes it an interesting model to
investigate reinnervation changes that may occur after
NT-3 administration.
 
We have recently demonstrated that the local delivery
of NT-3 to rat sciatic nerve enhances the rate and amount
of nerve regeneration, and at 8 mo postoperative, there
was a 40% increase in the myelinated fiber count (Sterne
et al., 1997). However, enhanced regeneration by itself is
not necessarily indicative of a beneficial effect on the tar-
get muscles, such as reacquisition of more normal physio-
logical function. Therefore, the aim of this study was to as-
sess whether NT-3–enhanced nerve regeneration resulted
in biochemical or morphological changes in a target mus-
cle (gastrocnemius), which would be suggestive of signifi-
cant improvement of physiological function above that
seen after nerve repair without administration of neuro-
trophin. Immunohistochemistry, in conjunction with com-
puterized quantification and morphometrical analysis, was
used to analyze the number, size, and pattern of distribu-
tion of the MHC fiber types after denervation and reinner-
vation of the gastrocnemius muscle.
 
Materials and Methods
 
Surgical Procedure
 
8-wk-old inbred male Lewis rats were anesthetized using 0.3 ml/kg of in-
tramuscular Hypnorm (0.315 mg/ml fentanyl citrate and 10 mg/ml flu-
anisone; Janssen Pharmaceuticals Ltd.) and 2.5 mg/kg of intraperitoneal
diazepam (Phoenix Pharmaceuticals Ltd.).
Using an operating microscope (Wild Heerbrugg Ltd.), the left sciatic
nerve was exposed 5 mm distal to the sciatic notch via a gluteal muscle
splitting incision. A 5-mm length of nerve was removed using sharp micro-
surgery scissors to produce a gap of 10 mm after retraction of the nerve
ends. This gap was grafted with fibronectin impregnated with 500 ng/ml
NT-3 (NT) (Sterne et al., 1997); alternatively plain fibronectin mats (FN)
or autologous nerve grafts (NG) were inserted as controls.
During insertion, 14-mm-long fibronectin mats were entubulated, the
hydroscopic nature of the fibronectin causing them to expand, obliterating
the lumen. The proximal and distal nerve stumps were drawn into either
end of the entubulated mat to produce a resultant gap of 10 mm and two
10/0 monofilament nylon (Ethicon Ltd., Edinburgh, UK) interrupted su-
tures were used at each anastomosis. For autologous nerve grafts, a 1-cm
length of sciatic nerve was removed, reversed, and reanastomosed to bridge
the resulting defect. Animals received postoperative analgesia for 24 h
and were kept warm until fully recovered from the anesthetic before their
return to the holding room, where they had free access to food and water.
On the first postoperative day, the animals were caged in groups of three.
Samples from six animals from each group were harvested at 5, 10, 15,
30, 120, and 240 d postoperatively. The animals were killed and the calf
muscles approached by extending the lateral thigh incision beyond the an-
kle joint. Gastrocnemius muscles were removed bilaterally from each ani-
mal. Using an operating microscope, the entire gastrocnemius muscle was
carefully cleaned and dissected out, dividing its two tendinous origins and
tendinous insertion flush with the bone. Each muscle was then weighed
separately to allow calculation of the percentage reduction in muscle mass
(denervated muscle weight vs. contralateral muscle weight) after denerva-
tion and reinnervation. For the animals harvested at 240 d only, the effects
of reinnervation on the gastrocnemius muscle were investigated immuno-
histochemically. To ensure biopsy of a constant part of the muscle, while
holding the knee joint fully extended and the ankle joint flexed to 90
 
8
 
, the
midpoint of the gastrocnemius muscle, lying half way between the knee
and ankle, was identified and marked with a blue surgical marking pen.
The muscles were then harvested as before.
 
Immunohistochemistry
 
After weighing, a transverse disc of the whole muscle 5 mm long was cut
and carefully orientated on a small piece of cork to allow transverse sec-
tions to be made. The muscle specimen, embedded in OCT, was rapidly
frozen by rapid inversion and plunging into isopentane cooled in liquid ni-
trogen for about 30 s.
A panel of mouse monoclonal antisera was used for immunostaining, 
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and it included BA-F8 antibodies raised against rat MHC 1, SC-71 anti-
bodies raised against rat MHC 2a, and BF-F3 antibodies raised against rat
MHC 2b. All primary antibodies were used at a 1:200 dilution in PBS, pH
7.4. Antibodies to the MHCs (Schiaffino et al., 1989) were supplied by Re-
generon Pharmaceuticals, USA.
Serial 8-
 
m
 
m transverse cryostat sections were cut from each muscle
block, collected on Vectabond-coated slides (Vector, UK), and air dried
for 30 min at room temperature before immunofluorescent staining. The
sections were permeabilized by immersion in 0.2% Triton X-100 in PBS
(Merck/BDH, UK) for one hour, rinsed three times in PBS, and incubated
in 3% goat serum (TCS Biologicals, UK) in PBS to block any background
binding from the secondary labeled antibody. Sections were then incu-
bated with the primary antibodies for 24 h at 4
 
8
 
C in a humid chamber,
washed in PBS/Tween (0.02%) to remove nonspecifically bound antibody,
rinsed three times in PBS, and incubated with cyanine-3–conjugated goat
anti–mouse serum (Affinity, UK, diluted 1:100 in PBS). Nonspecifically
bound second layer antibodies were again removed by washing with PBS/
Tween, and the sections were then rinsed in PBS and mounted with PBS/
glycerol containing 2.5% (wt/vol) 1,4-diazabicyclo [2.2.2] octane (Aldrich
Chemical, Gillingham, UK) as an antifading agent.
 
Quantification and Morphometric Analysis
 
All morphometric measurements were performed on coded sections with-
out knowledge of their source. The sections were viewed using an Olym-
pus (Lake Success, NY) microscope connected to a computerized image
analysis system (Seescan Analytical Services, Cambridge, UK) appropri-
ately calibrated for each objective magnification. Six fields (10
 
3
 
 objective)
were chosen at random from each muscle section providing a minimum of
100 positive fibers from each section. After image capture, background
subtraction, image enhancement, thresholding, and final editing, auto-
matic counting and measurement of the diameter of each positive fiber
was performed using a dedicated calibrated software program.
An assessment of the degree of fiber type distribution was performed
by placing a randomly orientated line from an eyepiece graticule across
the entire muscle section, and the number of fibers in each group of posi-
tive and negative fibers along this line were recorded. 10 random linear
transects were made on each muscle, counting a minimum of 900 fibers.
These counts were used as a representative indication of the total number
of muscle fibers in each whole muscle section and allowed to quantify the
proportion, diameter, and size distribution of each fiber type in each ex-
perimental group.
 
Statistical Analysis
 
Statistical analysis was carried out using the STATA (STATA Corpora-
tion, College Station, TX) and SIGMASTAT (Jandel Scientific, Erkrath,
Germany) software packages. A one-way analysis of variance (ANOVA)
was used to analyze the results of the muscle masses, fiber type distri-
butions, and diameters. The normality assumption of ANOVA was
checked using Shapiro-Francia’s W
 
9
 
 test and Bartlett’s test was used to
check the equal variance assumption. If data violated the assumptions of
normality and variance they were compared using a Kruskal-Wallis one-
way ANOVA on ranks, and data was then expressed as the median values
(25th–75th centiles). Differences between individual groups were subse-
quently isolated by the use of an appropriate all pair-wise multiple com-
parison procedure. To statistically analyze the size distribution profiles,
the 5th and 95th centiles of each fiber type in normal muscle were calcu-
lated and the frequencies and percentages of muscle fibers in each group
that were smaller, intermediate, or larger than these centiles were then
compared using Fisher’s exact test, introducing a Bonferroni adjustment
to allow for the number of comparisons made.
 
Results
 
Effect of NT-3–enhanced Nerve Regeneration on 
Muscle Atrophy
 
The mass of both gastrocnemius muscles in each animal
was recorded to allow calculation of the percentage atro-
phy (mass of denervated muscle/mass of normal contralat-
eral muscle
 
 3 
 
100) in each group at each time point (Fig. 1).
After denervation, initially there was a rapid loss of mus-
 
cle mass equally in each group up to day 15. By day 30, the
muscles in the groups repaired with fibronectin conduits
continued to lose muscle mass at an equal rate; however,
in the animals repaired with autologous nerve grafts, the
reduction in muscle mass was significantly less (
 
P
 
 , 
 
0.05).
At subsequent time points, the NT group showed steady
recovery of the muscle mass, which reached 47% of the
weight of contralateral normal muscle at 8 mo. The degree
of recovery of muscle mass was higher after NT-3 adminis-
tration than in the FN group, which reached only 39% nor-
mal muscle weight at the final time point. This difference
failed to reach significance at 120 d but was significant at
240 d (
 
P
 
 , 
 
0.05). The muscle in the NG group returned to
71% of their original mass by day 120 but remained stable
at this level by day 240 (
 
P
 
 , 
 
0.001 NG vs. NT and FN).
 
Changes in Distribution of Muscle Fiber Types after 
Denervation and Reinnervation
 
Type 1 Fibers. 
 
Fibers staining positive for MHC 1 were
confined to the deeper third of the contralateral normal
muscle, distributed in a mosaic pattern, and were rarely
seen in the peripheral superficial two thirds of the gastroc-
nemius muscle. After reinnervation, the distribution of
these groups was much more scattered throughout the
muscle: although MHC 1 staining fibers predominated in
the deeper parts of the muscle, there were considerable
numbers of groups in more superficial regions. There was
no obvious difference between experimental groups in the
redistribution patterns of type 1 fibers after reinnervation.
 
Type 2a Fibers. 
 
In normal muscles, MHC 2a staining fi-
bers had a similar distribution to that of MHC 1 fibers,
namely a mosaic distribution within the deep third of the
muscle with few fibers in the superficial two thirds. After
reinnervation, this pattern was disrupted with groups
present throughout the muscle but with a slight prepon-
Figure 1. The percentage reduction in gastrocnemius muscle
mass at various times after sciatic nerve division and repair. Each
data point represents the mean of six animals. Error bars show
the standard error of the mean. *P , 0.05 for NG vs. NT and FN,
ANOVA. **P , 0.001 for NG vs. NT and FN, ANOVA. ***P ,
0.05 for NT vs. FN, ANOVA. NG, autologous nerve graft repair;
NT, repair with NT-3–impregnated fibronectin mats (500 ng/ml);
FN, repair with plain fibronectin mats. 
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derance for the deeper parts remaining; again, no obvious
intergroup differences were noted.
 
Type 2b Fibers. 
 
Staining for MHC 2b shows a fiber distri-
bution mainly in the superficial two thirds of the gastroc-
nemius muscle and to a lesser extent in the deep muscle
regions. The usual mosaic distribution pattern was evident
in all areas of the muscle (Fig. 2 
 
a
 
). Reinnervation resulted
in significant disruption of the mosaic pattern (Fig. 2 
 
b
 
),
but the general preponderance of MHC 2b stained fibers
within the superficial two thirds of the muscle persisted; no
difference was evident between experimental groups.
 
Preferential Effect of NT-3–mediated Reinnervation
on MHC Fiber Type
 
From 10 transects across the entire section of each muscle,
a minimum of 900 fibers were counted, allowing a compar-
ison of the estimated number of muscle fibers (Table I)
and of the percentage distribution of each fiber type in
each group (Table II). From these counts it was evident
that there was no statistical difference between mean fiber
counts from different groups. An interesting difference in
fiber proportions was noted for type 2b fibers (Table II).
After reinnervation, the percentage of type 2b fibers in the
NT group was similar to that in normal muscle and signifi-
cantly greater than in either of the NG or FN groups (
 
P
 
 ,
 
0.05). In contrast, the type 2b proportion fell significantly
in the NG and FN groups compared with normal muscle
(
 
P
 
 , 
 
0.01).
The proportion of type 1 muscle fibers fell significantly
from normal levels following denervation and reinnerva-
tion (
 
P
 
 , 
 
0.02), with no differences between experimental
groups in the reinnervated muscles. The proportion of
type 2a muscle fibers in all experimental groups rose sig-
nificantly compared with normal after reinnervation (
 
P
 
 ,
 
0.01), without differences between the three groups. 
 
NT-3–dependent Changes of Muscle
Fiber Morphometry
 
Consistent with the results of percentage distribution of fi-
ber types, morphometric analysis of muscle fiber diame-
ters showed that type 2b fibers regained normal average
size after NT-3–mediated reinnervation (Table III). Con-
versely, in the two control groups the diameter of type 2b
fibers was significantly smaller than in muscle of normal
and NT groups (
 
P
 
 , 
 
0.01). The diameters of type 2a fibers
in reinnervated muscles of all groups were significantly
smaller than in normal muscles (
 
P
 
 , 
 
0.01). This was also
the case for type 1 fibers (
 
P
 
 , 
 
0.01), with the exception of
the NG group, where they recovered normal size.
Analysis of distribution profiles of individual muscle fi-
ber diameters (Fig. 3, 
 
a
 
–
 
c
 
) showed that the distribution
profile of type 2b fibers for the reinnervated NT group
closely resembled that seen in control muscle (
 
P
 
 5 
 
1, NT
vs. control). The distribution profiles for the NG and FN
groups contained more small fibers and fewer large fibers,
with a pattern different from both control and NT groups.
The difference was particularly evident after reinnervation
without NT-3 administration (FN group), where there was
Figure 2.( a ) Transverse immunofluorescent sections of normal gastrocnemius muscle stained for MHC 2b, demonstrating the typical
size and mosaic pattern of distribution. (b) 8 mo after repair of a 1-cm-long sciatic nerve defect using a plain fibronectin mat, the MHC
2b immunoreactive fibers are generally smaller, and there is a loss of the mosaic pattern of fiber type distribution. Bar, 50 mm.
 
Table I. The Mean Number of Fibers Counted in 10 Transects 
of the Whole Muscle in Each Group
 
Normal NG NT FN
 
Mean fiber count 
 
6 
 
SEM 1,353 
 
6
 
 66 1,347 
 
6
 
 99 1,179 
 
6
 
 42 1,185 
 
6
 
 87
 
NG
 
, autologous nerve graft repair; 
 
NT
 
, repair with NT-3–impregnated fibronectin
mats; 
 
FN
 
, repair with plain fibronectin mats.
 
Table II. The Percentage Distribution of Fiber Types in Each 
Group (n 
 
5
 
 6)
 
Percentage 
 
6
 
 SEM
Normal NG NT FN
 
MHC 1 21.4 
 
6
 
 3.2 13.3 
 
6
 
 1.9** 12.3 
 
6
 
 1.7** 11.9 
 
6
 
 1.5**
MHC 2a 15.8 
 
6
 
 0.6 21.8 
 
6
 
 1.7*** 25.9 
 
6
 
 1.1*** 29.8 
 
6
 
 1.7***
MHC 2b 44.3 
 
6
 
 3.5 33.8 
 
6
 
 0.9*** 43.3 
 
6
 
 1.3* 35.7 
 
6
 
 1.1***
 
P
 
 
 
,
 
 0.05, NT vs. NG and FN (MHC 2b); **
 
P
 
 
 
,
 
 0.02, normal vs. reinnverated muscle
(MHC 1); ***
 
P
 
 
 
,
 
 0.01, normal vs. reinnervated muscles (MHC 2a and 2b). ANOVA,
Dunns method. 
 
NG
 
, autologous nerve graft repair; 
 
NT
 
, repair with NT-3–impregnated
fibronectin mats; 
 
FN
 
, repair with plain fibronectin mats. In all experimental groups,
there is a percentage of undefined fibers not represented in the table. These fibers are
derived from the inability to label specific MHC IIx/d. 
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a statistically significant difference from both control and
NT groups (
 
P
 
 , 
 
0.005).
Reinnervated muscle in all experimental groups demon-
strated a shift towards small type 1 fibers compared with
normal muscle, though a few large fibers were still present.
Instead, type 2a fibers showed a shift toward intermediate
size fibers, with fewer large and small diameter fibers than
normal muscle. For both type 1 and 2a fibers, statistical
analysis confirmed a significant shift toward smaller sizes
(
 
P
 
 , 
 
0.005 for each group vs. normal).
 
Discussion
 
Here we present evidence that NT-3 improves motor tar-
get organ reinnervation in terms of recovery of both nor-
mal proportions of type 2b muscle fibers and their return
to normal diameter. These results are consistent with our
previous report that the local delivery of NT-3 to injured
sciatic nerves in rats enhances both the rate and amount of
axonal regeneration (Sterne et al., 1997).
After denervation, the gastrocnemius muscle was found
to lose weight rapidly, falling to 
 
z
 
30% of its original weight
by day 30, consistent with similar results reported previ-
ously (Sunderland, 1978). At day 30, muscles in the NG
group were significantly less atrophic than in both fi-
bronectin groups. It is likely from the results of the regen-
eration rate in the NG group (Sterne, G.D., unpublished
results) that by day 30 the muscle was already becoming
reinnervated. By day 120, the recovery of muscle mass
seen after NT-3 administration was improved compared
with control FN group, although it was still less than after
nerve grafts. The muscle recovery of the NT-3 group was
maintained and actually improved with statistical signifi-
cance by 8 mo. This correlates well with our previously re-
ported myelinated fiber counts distal to the nerve repair
in which NT-3–impregnated mats supported a significant
improvement in myelinated fibers at 8 mo after repair
 
Table III. Diameters of the Different Fiber Types in
Each Group
 
Diameters
Normal NG NT FN
 
m
 
m
 
MHC 1 67.8 65 54.7* 58.4*
(60.9–76.8) (50.4–77.5) (34.2–73.9) (49.7–65.4)
MHC 2a 64.8 53.2* 54.5* 49.5*
(52.9–75) (45.8–59.8) (47.6–63.9) (43.7–57.6)
MHC 2b 86.7 81* 87.8 70.8*
(77.8–97.3) (71.3–92.8) (80.7–98.3) (61.2–82.7)
 
Measurements are given in microns as the median values (25th–75th centiles) of each
group (
 
n
 
 
 
5
 
 6). *
 
P
 
 
 
,
 
 0.01 for normal vs. reinnervated muscles, ANOVA on ranks,
Dunns method. 
 
NG
 
, autologous nerve graft repair; 
 
NT
 
, repair with NT-3–impregnated
fibronectin mats; 
 
FN
 
, repair with plain fibronectin mats.
Figure 3. (a) The size distribution of type I muscle fibers in each group. Note how after regeneration there is a general reduction in fiber
diameter, with each of the reinnervated groups being significantly different from normal (P , 0.005; Fisher’s exact test, Bonferroni ad-
justment). However, some muscle fibers in each group regain normal diameter. (b) Size distribution profiles of type IIa muscle fibers by
group. There is a significant loss of large fibers in all groups but significantly fewer small diameter muscle fibers (P , 0.005; Fisher’s ex-
act test, Bonferroni adjustment). Overall, there is a tendency toward slightly smaller muscle fiber diameters in the reinnervated muscle
compared with normal fibers. (c) Size distribution profiles of type IIb muscle fibers by group. The distribution profiles of the reinner-
vated NT group resembled the profile seen in normal muscle (P 5 1 for NT vs. normal; Fisher’s exact test, Bonferroni adjustment), but
the profile for muscle fibers in the FN group was significantly different from both normal and the NT group (P , 0.005; Fisher’s exact
test, Bonferroni adjustment). Normal, normal gastrocnemius muscle; NG, autologous nerve graft repair; NT, repair with NT-3–impreg-
nated fibronectin mats (500 ng/ml); FN, repair with plain fibronectin mats.The Journal of Cell Biology, Volume 139, 1997 714
(Sterne et al., 1997). By comparison, the muscles in the
NG group had regained some 70% of their original mass
at 4 mo. However, the benefit did not progress, remaining
unchanged up to 8 mo postoperatively. This level of recov-
ery is similar to that reported after nerve transection and
muscle reinnervation (Gillespie et al., 1987; Bertelli et al.,
1995), though nerve crush injury, with the preservation of
Schwann cell basal lamina tubes, results in greater muscle
recovery (Bertelli et al., 1995). 
The mechanism by which NT-3 exerts its effect on mus-
cle is uncertain. NT-3 may act directly on motoneurons,
for example by enhancing survival (Eriksson et al., 1994;
Lefebvre et al., 1994) or stimulating axonal branching
(Schnell et al., 1994; Isaacson et al., 1996). This might ex-
plain the increased number of myelinated axons previously
observed in NT-3–treated animals (Sterne et al., 1997), which
in turn may lead to reinnervation of greater numbers of
muscle fibers. Alternatively, NT-3 may be acting via mus-
cle afferent innervation. Recent studies have shown that in
transgenic mice, NT-3 overexpression in muscle influences
the survival of proprioceptive sensory neurons (Ozaki et al.,
1996; Henderson et al., 1996) and increases the number of
muscle spindles in gastrocnemius muscle without an over-
all increase in motoneuron numbers (Wright et al., 1996).
Consistently, deletion of NT-3 during development results
in a decreased survival of muscle sensory afferents during
development (Ernfors et al., 1994; Kucera et al., 1995a,b;
Oakley et al., 1995). It may be possible that after nerve in-
jury, the survival or enhanced regeneration effect of NT-3
on this subpopulation of neurons leads to a greater rein-
nervation of muscle spindles and Golgi tendon organs,
consequently resulting in improved sensory feedback from
the muscle. This in turn would result in greater use of the
muscle and hence lead to improvement in muscle mass.
Our data show that there are specific and highly signifi-
cant effects of both nerve graft and NT-3 treatment upon
type 1 and 2b muscle fibers, respectively. Nerve graft, by
the nature of it, offers the regenerating nerve an almost
ideal environment because of the presence of activated
Schwann cells and a scaffolding of basal lamina to facili-
tate the progression of regenerating axons. However, treat-
ment by nerve graft normalized type 1 fiber size but did
not bring their proportion back to normal, while NT-3
treatment normalized both size and proportion. It should
be remembered that we were unable to analyze MHCx/d,
and therefore we cannot say if the increase in muscle mass
seen in the NG group was also the result of the presence of
large and numerous IIx/d fibers.
After reinnervation, morphometric analysis showed that
the diameter distribution of type 2b fibers showed a pat-
tern similar to normal only in the NT group. Furthermore,
the general trend for the other fiber types in all experi-
mental groups showed a shift to smaller diameter sizes.
Analysis of the proportion of different muscle fiber types
in each group at 8 mo postoperatively revealed a general-
ized reduction of type 1 fibers and a significant increase of
type 2a fibers. By contrast, the proportion of type 2b mus-
cle fibers was restored to normal only in the NT group.
This result is consistent with the enhanced diameters of
type 2b fibers in NT-3–treated animals, which uniquely re-
turn to the same size as in normal muscle. This result is
strongly indicative that NT-3 applied to the cut nerve may
influence the regeneration of a physiologically distinct
subset of motor neurons supplying type 2b muscle fibers.
While functional assessment of NT-3–enhanced reinner-
vated muscles has yet to be performed, it is known that for
reinnervated muscle, as in normal muscle, force generated
is proportional to cross-sectional area of muscle fibers
(Schantz et al., 1983; Davis et al., 1988; Totosy de Zepet-
nek et al., 1992) and increase in diameter and proportion
of 2b fibers seen in the NT group is likely to result in in-
creased force generation.
In conclusion, we have demonstrated that NT-3 enhance-
ment of peripheral nerve regeneration does have a benefi-
cial biochemical and morphological effect on the reinner-
vation of motor target organs, supporting the hypothesis
of a specific phenotypic effect of growth factor–enhanced
nerve regeneration. This is the first indication of a differ-
ential effect of NT-3 on neuromuscular interaction in nor-
mal adult animals in vivo. It seems doubtful that muscle
reinnervation alone may be able to provoke a selective re-
sponse from the muscle fibers, and it is likely that a more
complex signaling system, possibly involving neurotrophic
factors, may be involved. This still awaits clarification, but
these results also suggest the remarkable possibility that
other subpopulations of motoneurons, as classified by the
phenotype they confer on muscle fibers, may be differen-
tially responsive to other neurotrophic factors, and this
leads us to believe that single or combined application of
trophic factors might prove of future therapeutic value.
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